Skip to main content
Premium Trial:

Request an Annual Quote

Quest Diagnostics Divests OralDNA Labs

NEW YORK (GenomeWeb News) – Quest Diagnostics today said that it has sold substantially all of the assets of its OralDNA Labs business to Access Genetics for an undisclosed sum.

The business, which currently provides saliva-based testing from a facility in Tennessee, will be consolidated with Access Genetics' CLIA- and CAP-certified lab in Eden Prairie, Minn. Quest noted that Access Genetics has provided support and expertise for OralDNA-based testing services for dental professionals since 2008.

The divestiture is part of Quest's ongoing efforts to refocus on its core diagnostic information services business for physicians and hospitals. The firm's management discussed those efforts in great detail during the firm's first-ever Investor Day last month.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.